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Amphiphilic block copolymers tend to self-assemble in an aqueous phase and form
micelles. These polymeric micelles have nanoscale, high thermodynamic and kinetic sta-
bility and can solubilize hydrophobic substances; therefore, they may be applied to sepa-
ration systems, drug delivery systems, pharmaceuticals, or emulsion stabilization (1–3).
Polymeric micelles composed of block copolymers show a core-shell micellar structure
with a hydrophobic inner core surrounded by a hydrated outer shell in aqueous solu-
tion. Hydrophobic drugs can be incorporated into the hydrophobic inner core and the
hydrated outer shell helps prevent opsonization of the carrier and uptake by the reticu-
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The objective of this work was to study the effect of fatty
acid chain length grafted to methoxy poly(ethylene gly-
col) (mPEG) on self assembling properties of micelles for
etoposide delivery. Three amphiphilic copolymers were
synthesized using mPEG, myristic acid, stearic acid and
behenic acid through an esteric linkage. The particle size
and zeta potential of the micelles were determined by the
dynamic light scattering method. Etoposide was loaded
into micelles by film casting using various drug/polymer
ratios. Drug release was studied by the dialysis method.
The structure of copolymers was confirmed by 1H NMR
and FTIR. Central micellar concentration (CMC) measu-
rements showed that the longer hydrophobic chains for-
med more thermodynamically stable micelles. Among the
prepared copolymers, etoposide showed the highest solu-
bility in the mPEG-behenic copolymer. Drug loading ef-
ficiency depended on the hydrophobic chain length and
drug/polymer ratio. The highest drug loading efficiency
was found in mPEG-myristic micelles with 1:20 drug/po-
lymer ratio. Micelles released 80 % of loaded drug within
about 5 h.
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loendothelial system. Polymeric micelles have the advantages of small particle size,
good structural stability, easy production in large quantities and reproducibly, favorable
biodistribution, easy sterilization and improved solubility and bioavailaibility of poorly
water-soluble anticancer drugs (4, 5). Polymeric micelles can therefore increase the quan-
tities of drug delivered to the cells with high efficacy and low side effects (6–8). Since
water concentration in the micellar core is low, hydrolytic degradation may be reduced,
resulting in increased chemical stability of the drug.
Etoposide is a lipophilic anticancer agent used in the treatment of various malig-
nancies (9). It is a topoisomerase-II inhibitor that acts through activation of oxidation-
-reduction reactions to produce derivatives that bind directly to DNA and cause DNA
damage (9, 10). Etoposide has a short biological half-life (3.6 hours), with terminal
half-life of 1.5 hours by intravenous route and variable oral bioavailability ranging from
24–74 %. Although intraperitoneal injection would result in initial high local tumor con-
centrations, prolonged exposure of tumor cells may not be possible (11). The tumoricidal
effects of etoposide incorporated into lipid nanoparticles after a single-dose administra-
tion showed stronger and prolonged apoptotic induction properties, resulting in higher
increase in the survival time of tumor bearing mice (11).
The aim of the present study was to improve water solubility of etoposide by pre-
paring etoposide-loaded nanomicelles of mPEG and fatty acids.
EXPERIMENTAL
Materials
Myristoyl chloride, stearoyl chloride and behenoyl chloride were purchased from
Aldrich Company (USA), mPEG (Fluka, USA), pyrene (Sigma, USA) and etoposide
(Beijing Lunarsun Pharmaceutical Co., Ltd., China). KBr, NaOH, KHPO4 and all solvents
such as toluene and triethylamine used in this study were of analytical grade and were
purchased from Merck (Germany).
Synthesis of mPEG-fatty acid conjugate
For conjugation of mPEG to fatty acids [myristic acid (Ma) (C14), stearic acid (Sa)
(C18) and behenic acid (Ba) (C22)], the acyl chloride form of fatty acids was used by the
modified method reported by Sahu et al. (12). mPEG was mixed and dissolved in tri-
ethylamine (final concentration 10 mmol L–1). A solution of acyl chloride (11 mmol L–1)
in toluene was added dropwise and stirred continuously for 3 h at 60 °C. The solution
was then filtered through filter paper (Whatman, UK) to remove the precipitated tri-
ethylamine hydrochloride salt. NaOH (0.5 mol L–1) solution was then added to remove
unreacted acyl chloride and mPEG. The toluene that remained in the solution was re-
moved by vacuum distillation to produce a dry powder.
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Fourier transform infrared spectroscopy
Infrared spectra of polymers were measured on an FTIR spectrometer (Rayleigh,
WQF-510/520, China) at wavenumbers 500–4000 cm–1 with a resolution of 4 cm–1 using
the KBr disc method.
Nuclear magnetic resonance spectroscopy
Two mg of mPEG-Ma was dissolved in 0.5 mL of chloroform while mPEG-Sa and
mPEG-Ba (2 mg) were dissolved in 0.5 mL of DMSO. The 1H NMR analysis was carried
out on a Bruker ARX 400-MHz (Germany) instrument.
Experimental design
Studied variables were: the type of fatty acid and the amount of drug per 100 mg of
copolymer while the studied responses were particle size, zeta potential, loading effi-
ciency of etoposide in the micelles and drug release efficiency from mPEG-fatty acids.
Each variable was studied at three levels. The levels were selected in accordance with
preliminary studies (data not shown). D-optimal criteria, one of several »alphabetic«
optimalities, were developed to select design points in such a way to minimize the vari-
ance associated with the estimates of specified model coefficients. Central composite de-
sign (CCD) is widely applied in many fields to construct a second-order response sur-
face model with quantitative factors to help increase the precision of the estimated
model. When an experiment also includes qualitative factors, the effects between quanti-
tative and qualitative factors should be taken into consideration. It is shown that, at each
qualitative level, the corresponding D-optimal design also consists of three portions as
CCD, i.e., the cube design, the axial design and center points, but with different weights.
The reasons for using D-optimal designs instead of standard classical designs generally
fall into two categories: (i) standard factorial or fractional factorial designs require too
many runs for the amount of resources or time allowed for the experiment, and (ii) the
design space is constrained (process space contains factor settings that are not feasible or
are impossible to run). D-optimal designs are a form of design provided by a computer
algorithm. These types of computer-aided designs are particularly useful when classical
designs do not apply. Unlike standard classical designs such as factorials and fractional
factorials, D-optimal design matrices are usually not orthogonal and effect estimates are
correlated. A D-optimal design minimizes the determinant of the (X’X)–1 matrix. This will
minimize the volume of the confidence ellipsoid for the coefficients. Equivalently, D-op-
timality maximizes the determinant (X’X), which is called the »information« matrix. The
key is that these designs are built algorithmically to provide the most accurate estimates
of the model coefficients (13).
The design matrix was built and analyses were performed by the statistical software
package Design-Expert (version 7.0.0, Stat-Ease, Inc., Minneapolis, MN, USA). Table I
shows the factors and different formulations of micelles. Some formulations are repea-
ted as checking points in the design. In this study, all experiments were performed in
triplicate and the averages were considered as response(s). The significance of the effect
of independent variables on the response was evaluated by ANOVA through Fisher’s
test and shown by p < 0.05.
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Preparation of self-assembled micelle nanoparticles of the mPEG-fatty acid conjugate
and measuring the CMC
In general, the hydrophobic fatty acid segment of the mPEG-fatty acid molecule was
self-associated as a hydrophobic core, while the hydrophilic mPEG segments were pu-
shed into the aqueous phase surrounding the core to form micelles. Self-aggregation be-
havior of mPEG-fatty acid in aqueous medium was determined by the dye solubiliza-
tion method using pyrene as a probe molecule. Pyrene fluorescence probing is a widely
used methodology for measuring the CMC of micelles. This method is based on changes
in the intensity of the vibrational bands of pyrene solubilized in water and in micellar
medium. Emission spectra of pyrene strongly depend on microenvironment polarity; in
a polar solvent, the intensity of the first energy band (377 nm, I1) is higher than the third
energy band (390 nm, I3) of the pyrene emission spectra while in a hydrophobic environ-
ment the intensity of I3 is higher than that of I1. Therefore, when micelles are formed in
aqueous medium, the pyrene is preferably partitioned into the hydrophobic core and the
intensity of I3 increases. As a result, the ratio of I1/I3 can be used to determine CMC.
Fifty mg of dry powder of the m-PEG-fatty acid conjugate was dissolved in 50 mg
of 0.1 mol L–1 phosphate buffer solution (PBS) prepared from KH2PO4 (pH 7.4) as the
stock solution and sonicated for 30 min to get an optically clear solution. The critical
micellar concentration of mPEG-fatty acid was determined using pyrene as a hydropho-
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Table I. Formulation of different micelles prepared according to the 2-factor, 3-level D-optimal design
Etoposide
(% in copolymer)
Fatty acid type Micelle formulation
5.0 Myristic acid mPEG-Ma5
a
5.0 Myristic acid mPEG-Ma5
a
7.5 Myristic acid mPEG-Ma7.5
10.0 Myristic acid mPEG-Ma10
15.0 Myristic acid mPEG-Ma15
a
15.0 Myristic acid mPEG-Ma15
a
5.0 Stearic acid mPEG-Sa5
a
5.0 Stearic acid mPEG-Sa5
a
7.5 Stearic acid mPEG-Sa7.5
10.0 Stearic acid mPEG-Sa10
15.0 Stearic acid mPEG-Sa15
a
15.0 Stearic acid mPEG-Sa15
a
5.0 Behenic acid mPEG-Ba5
7.5 Behenic acid mPEG-Ba7.5
10.0 Behenic acid mPEG-Ba10
15.0 Behenic acid mPEG-Ba15
a
15.0 Behenic acid mPEG-Ba15
a
a Repeated formulations are check points proposed by the Design Expert software in D-Optimal Design.
bic fluorescence probe. CMC was determined based on the intensity of pyrene excitation
spectra and shift of the spectra with increasing mPEG-fatty acid concentration. A pyrene
solution (6 ´ 10–6 mol L–1) in acetone was added to the test tube and evaporated to re-
move the solvent. Solution of mPEG-fatty acid micelles in PBS (pH 7.4) was then added
to the test tube in concentration ranging from 0.001 to 1 mg mL–1, bringing the final con-
centration of pyrene to 6.0 ´ 10–7 mol L–1. The solution was vortexed and kept overnight
at 37 °C to equilibrate pyrene with the micelles (14). Measurements of fluorescence in-
tensity were carried out at lex = 334 nm and lem = 377 and 390 nm. The change in the ra-
tio of fluorescence intensity (I377/I390) of pyrene with the log (concentration) of mPEG-
-fatty acid was recorded for determining CMC.
Particle size and zeta potential of micelles
Size and distribution of the micelles were measured by the dynamic light scattering
method (DLS, Zetasizer ZEN3600, Malvern Instruments Ltd., UK). The test was perfor-
med at 25 °C at a scattering angle of 90°. Prior to measurements, the micelle solution (1.0
mg mL–1) was passed through a 0.45-mm pore size filter.
Hydrophilic-lipophilic balance (HLB) values of the mPEG-fatty acid conjugate
The HLB value of copolymers was measured using the relative molecular mass of
mPEG-fatty acid conjugates as reported by Pasquali et al. (15).
Phase solubility
Phase solubility analysis was carried out according to the method described by Hi-
guchi and Connors (16). Excess of the drug was added separately into a screw-capped
vial containing 100 mg of mPEG-fatty acid in PBS. The vial was shaken for 48 hours in
an orbital water bath (Daiki Sciences Co, Korea) at 25 °C and allowed to stand for 24
hours to attain equilibrium. Solutions were filtered using a nylon membrane filter of
0.45 mm pore size. The pH of the filtered solution was checked. The sample was diluted
appropriately with PBS and analyzed in a UV Visible spectrophotometer (UV mini 1240,
Shimadzu, Japan) at 283.5 nm.
Encapsulation of etoposide in micellar nanoparticles
The encapsulation efficiency of etoposide was studied at different etoposide con-
centrations and different types of fatty acids used to synthesize mPEG-fatty acid copoly-
mers. Etoposide solution in acetone was added to the solution of mPEG-fatty acid in ac-
etone to obtain different drug to polymer ratios ranging from 1:20 to 3:20.
Acetone was evaporated under vacuum to produce a film consisting of an mPEG-
-fatty acid/etoposide mixture. Micelles were formed by extensive vortexing of the film
in PBS (pH 7.4). Nonencapsulated etoposide was separated by centrifugation (Eppen-
dorf 5430 centrifuge, Germany) of the micelle suspension at 6720´g for 5 min in Amicon
ultra centrifugal filter Eppendorf tubes (Millipore Ireland, cut-off 10000 Da) and quanti-
fied spectrophotometrically at 283.5 nm.
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In vitro drug release from etoposide-loaded polymeric micelles
To determine the release rate of etoposide from nanoparticles, 5 mL of an aqueous
dispersion of each formulation was added to a dialysis bag with molecular mass cut-off
of 12400 Da and sealed bags were placed in a glass test-tube in 50 mL of PBS 0.1 mol L–1
(pH 7.4) under agitation. Samples of 0.5 mL were withdrawn at predetermined time
points and were immediately replaced with fresh PBS maintained at the same tempera-
ture. The content of etoposide in the samples was determined.
RESULTS AND DISCUSSION
Synthesis and characterization of mPEG-fatty acid copolymers
The mPEG-Ma, mPEG-Sa and mPEG-Ba block copolymers were synthesized by a
single-step reaction of mPEG with myristoyl chloride, stearoyl chloride and behenoyl
chloride, respectively. They reacted with the hydroxyl group of mPEG to provide an es-
ter linkage. The structure of mPEG-fatty acid block copolymers was characterized by
1H NMR and FTIR. Figs. 1a-c show the 1H NMR spectra of mPEG-Ma, mPEG-Sa and
mPEG-Ba, respectively. In the 1H NMR spectra of mPEG-Ma (Fig. 1a), the characteristic
chemical shifts of mPEG were 3.56 ppm (d) and 3.28 ppm (c) due to the methylene pro-
tons of PEG oxyethylene unit and protons of the methoxy end group, respectively. Cou-
pling of the myristate residue to mPEG was characterized by signals at 2.25 ppm (a),
1.55 ppm (b) and 4.13 ppm (e). Fig. 1b relates to the mPEG-Sa conjugate, which shows
the characteristic chemical shifts of mPEG at 3.51 ppm (d) and 3.24 ppm (c) due to methy-
lene protons of PEG oxyethylene units and protons of the methoxy end group, respecti-
vely. Coupling of the stearate residue to mPEG was characterized by signals at 2.28 ppm
(a), 1.51 ppm (b) and 4.11 ppm (e). Fig. 1c shows the 1H NMR spectrum of the mPEG-Ba
block copolymer. In the 1H NMR spectra, the characteristic chemical shifts of mPEG
were at 3.54 ppm (d) and 3.36 ppm (c) due to methylene protons of PEG oxyethylene
unit and protons of the methoxy end group, respectively. Coupling of the residue to
mPEG was characterized by signals at 2.20 ppm (a), 1.48 ppm (b) and 4.06 ppm (e). From
the peak integrity ratio of the methylene groups, the molar ratios of repeating units in
mPEG and Ma, Sa and Ba blocks could be calculated.
The FTIR spectra of mPEG-Ma, mPEG-Sa and mPEG-Ba are seen in Figs. 2a-c, re-
spectively. The FTIR spectrum of conjugates shows a sharp peak due to the stretching vi-
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PBS (pH 7.4) (mg mL–1)
Mr Copolymer
128 10.56 87 761.32 mPEG-Ma
99 8.25 90 817.43 mPEG-Sa
80 5.93 94 873.54 mPEG-Ba
bration of the ester bond: mPEG-Ma conjugate shows a sharp peak at 1738 cm–1 (Fig.
2a), mPEG-Sa at 1732 cm–1 (Fig. 2b) and mPEG-Ba at 1730 cm–1 (Fig. 2c). These peaks
were not present in the spectrum of mPEG, which confirms the formation of mPEG-Ma,
mPEG-Sa and mPEG-Ba conjugations via ester linkage.
Drug solubility in micelles and HLB
Table II shows the results of measuring etoposide solubility in micelles and the HLB
values of copolymers. Theoretic Mr of the copolymers is also shown in that table. As the
results show, mPEG-Ma has the lowestMr and the highest HLB and CMC values. Etopo-
side solubility in PBS in the presence of three copolymers shows that mPEG-Ba solu-
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Fig. 1. 1H NMR of: a) mPEG-myristic acid (mPEG-Ma), b) mPEG-stearic acid (mPEG-Sa), and c)
mPEG-behenic acid (mPEG-Ba) copolymer.
bilizes etoposide (94 mg mL–1) more than the other two copolymers (90 and 87 mg mL–1
for mPEG-Sa and mPEG-Ma, respectively) compared to the solubility of the drug in PBS
without copolymers (around 60 mg mL–1). This indicates a high increase in etoposide so-
lubility in the presence of prepared surfactant copolymers.
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Fig. 2. FTIR spectra of: a) mPEG-myristic acid (mPEG-Ma), b) mPEG-stearic acid (mPEG-Sa), and c)
mPEG-behenic acid (mPEG-Ba) copolymer.
Experimental design and validation
First, the number of factors and levels for optimization of etoposide-loaded micelles
were selected. To achieve optimum conditions meaning minimum particle size, maximum
drug loading and release efficiency, a surface response study based on D-optimal design
(14) was employed and the variables applied were: type of fatty acid with different chain
length and percent of drug in the copolymer. They were evaluated in 17 experiments (Ta-
ble I). Some of the repeated runs seen in Table I were selected by the software as check
points. As can be seen, the range of particle size in designed runs was 13–480 nm, zeta
potential was between –0.1 and –7.5 mV, drug loading was between 36 and 54 % and re-
lease efficiency until 5 h was between 39 and 52 % (Table III).
Multiple coefficients of determination and adjusted R2 were used as quality indicators
to evaluate the fitness of the second-order polynomial equations for calculating the par-
ticle size, loading efficiency and release efficiency of etoposide from the micelles. The si-
milarity between R2 for loading efficiency (R2 = 0.8582) and adjusted R2 values (R2 = 0.7938)
and also for other studied responses shows the adequancy of the model to predict the res-
ponse.
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Table III. Physical properties, loading efficiency and release characteristics of 17 formulations of micelles










b 18.4 ± 1.0 0.4 ± 0.1 –7.4 ± 1.6 54.0 ± 2.6 49.1 ± 2.3
mPEG-Ma5
b 12.9 ± 0.4 0.5 ± 0.0 –4.3 ± 1.5 52.0 ± 3.0 43.8 ± 2.5
mPEG-Ma7.5 48.5 ± 0.9 1.0 ± 0.0 0.9 ± 0.1 51.0 ± 3.0 53.3 ± 1.6
mPEG-Ma10 13.6 ± 5.4 0.4 ± 0.1 –3.2 ± 2.5 50.9 ± 3.2 39.3 ± 0.6
mPEG-Ma15
b 13.4 ± 2.2 0.4 ± 0.1 –3.0 ± 1.3 44.0 ± 1.7 45.8 ± 2.7
mPEG-Ma15
b 32.8 ± 2.2 0.6 ± 0.1 –5.3 ± 0.5 45.0 ± 3.0 43.2 ± 0.6
mPEG-Sa5
b 175.8 ± 12.0 0.7 ± 0.3 –2.0 ± 1.0 51.0 ± 2.6 46.8 ± 3.0
mPEG-Sa5
b 235.4 ± 27.0 0.6 ± 0.1 –2.1 ± 0.1 52.0 ± 3.5 38.9 ± 1.1
mPEG-Sa7.5 67.6 ± 7.1 1.0 ± 0.0 –0.8 ± 1.1 44.0 ± 2.6 48.2 ± 1.8
mPEG-Sa10 219.7 ± 8.6 0.6 ± 0.2 –1.5 ± 0.9 39.0 ± 4.0 49.6 ± 1.6
mPEG-Sa15
b 45.0 ± 3.7 0.5 ± 0.2 –6.3 ± 1.3 38.0 ± 3.6 46.0 ± 1.1
mPEG-Sa15
b 70.9 ± 1.4 0.5 ± 0.2 0.0 ± 0.1 36.0 ± 3.0 51.1 ± 4.6
mPEG-Ba5 478.9 ± 58.0 0.6 ± 0.1 –7.3 ± 0.4 49.0 ± 2.6 41.8 ± 1.8
mPEG-Ba7.5 39.0 ± 0.2 0.4 ± 0.1 0.0 ± 0.1 44 ± 3.4 58.8 ± 1.2
mPEG-Ba10 146.0 ± 2.6 0.3 ± 0.0 1.3 ± 0.7 51.0 ± 3.6 52.1 ± 9.9
mPEG-Ba15
b 119.7 ± 1.8 0.5 ± 0.1 –0.1 ± 1.1 48.0 ± 2.0 41.3 ± 5.4
mPEG-Ba15
b 118.9 ± 3.9 0.33 ± 0.06 –1.5 ± 1.0 52.0 ± 2.7 49.1 ± 1.1
a Calculated release efficiency (%) over 5 h.
b Repeated formulations are check points proposed by the Design Expert software in D-Optimal Design.
Mean ± SD (n = 3).
Optimal points were determined considering the goals to minimize the particle size
and to maximize drug loading and release efficiency. Design Expert software introduced
the optimum values of independent variables as 5 % drug in the mPEG-Ma of copolymer.
In order to validate the experimental model, three verification experiments were
performed using statistically optimized variables. Under these conditions, the predicted
value for particle size of micelles was about 11 nm, loading efficiency of 52.8 % and re-
lease efficiency of 49.8 %, which are close to the values reported for actual values of the-
se responses in Table III (mPEG-Ma5). The perfect agreement between the observed and
predicted values confirms the validity and precision of the model.
Micelle formation
The CMC of micelles was determined from the curve (Fig. 3) showing the relation-
ship between changes in pyrene intensity (I377/I390) with the concentration of mPEG-
-fatty acid. At low concentrations, the ratio of fluorescence intensity values reduces mar-
kadly, but with continuing increase of mPEG-fatty acid concentration the ratio of
intensity begins to become constant, implying the onset of self-assembly.
The CMC was calculated from the crossover point and its values for mPEG-Ma,
mPEG-Sa and mPEG-Ba were 128, 99 and 80 mg mL–1, respectively (Table II). This is
about 18–23 times lower than that of low molecular mass surfactant micelles like sodium
dodecyl sulphate with CMC of 2.3 mg mL–1 (17). It means that the prepared copolymers
can form micelles under highly diluted conditions.
The low CMC values indicate the thermodynamic stability of micelles (17). The CMC
values became lower with the increased molecular mass of the fatty acid block, indicat-
ing that the longer hydrophobic chain helped form more stable micelles (18). According
to the above CMCs, mPEG-Sa and mPEG-Ba copolymers were more stable than mPEG-
-Ma copolymers because of the longer chain of fatty acids. Rosen (19) has also shown
that in aqueous medium the CMC decreases as the number of carbon atoms in the hy-
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Fig. 3. Plot of flurescence intensity ratio (377 nm/390 nm) of pyrene vs. concentration of mPEG-
-fatty acid copolymers. The results are mean ± SD (n = 3).
drophobic group increases to about 16, and a general rule for ionic surfactants is that the
CMC halves by the addition of one methylene group to a straight chain hydrophobic
group attached to a single terminal hydrophilic group. For nonionics and zwitterionics,
the decrease of CMC with an increase in the hydrophobic group is somewhat larger.
When the number of carbon atoms in a straight chain hydrophobic group exceeds 16, the
CMC no longer decreases so rapidly with increasing the length of the chain, and when
the chain exceeds 18 carbons, it may remain substantially unchanged with further in-
crease in chain length. This may be due to the coiling of these long chains in water.
Micelle size and loading of etoposide in the micelles
Mean diameters for loaded micelles are shown in Table III. According to this table,
the mPEG-Ma copolymer loaded with 5 % etoposide has the smallest particle size (about
13 nm), and mPEG-Ba loaded also with 5 % etoposide has the biggest particle size
(about 479 nm). In other words, by increasing the hydrophohic chain length of micelles,
their particle size increased as well.
When the effect of each variable on the loading efficiency of etoposide in the mi-
celles is studied, one may conclude that the lowest loading efficiency is seen in mPEG-Sa
micelles while mPEG-Ma shows the highest loading efficiency, possibly due to the closer
solubility parameter between the drug and the core of the micelles. The Hildebrand solu-
bility parameter (d) provides a numerical estimate of the degree of interaction between
materials and can be a good indication of solubility, particularly for nonpolar materials
such as many polymers. Materials with similar values of d are likely to be miscible (20).
Increasing the drug/polymer ratio reduced the loading efficiency in Ma and Sa micelles
while this relationship was reverse in Ba. A possible reason may be the size of the core of
the micelles, which in Ma and Sa are lower than Ba. By increasing the drug ratio they
cannot accommodate the loading drug in the core and consequently the drug payload
will reduce, while in Ba micelles the core has enough space to keep increasing amounts
of the drug, causing a positive relationship between the drug/copolymer ratios with the
loading efficiency.
In vitro release of etoposide from loaded micelles
Fig. 4 shows in vitro release of etoposide from mPEG-Ma, mPEG-Sa, mPEG-Ba mi-
celles with different drug loadings. The drug release from each formulation was obser-
ved for 5 h. As it can be seen from Fig. 4, percent drug released at the end of the last
sampling time (i.e., at the end of 5 h) for different micellar formulations changes bet-
ween about 70 % (for mPEG-Ba5) to 90 % (for mPEG-Ma7.5). To include all release data,
release efficiency percent until 5 h (RE5, %), which is a model independent parameter,
was calculated from the area under the release curve until 5 h, expressed as percentage
of the curve at maximum release (i.e., 100 % drug release) over the same time period (Ta-
ble III). The main adventage of using RE is that no reference batch is needed and the re-
sult is closely related to the release behavior of micelles. As it is shown in Table III, RE5
(%) changes between 38.9 % (for mPEG-Sa5) and 58.8 % (for PEG-Ba7.5). This model in-
dependent parameter shows how efficiently the micelles can release the drug over the
sampling time in the release test. When each studied variable is considered, the micelles
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of Ma showed lower drug release compared to Sa and Ba, which may be due to higher
similarity of the solubility parameter (as defined earlier) of the drug to the core of the
Ma micelles causing, tighter entrapment of the drug and higher partitioning of etopo-
side in these micelles compared the other two fatty acids. On the other hand, the effect
of the other variable, i.e., the drug/polymer ratio, shows the highest release efficiency
related to 7.5 % drug in the copolymers. However, the combination effect of the two va-
riables, as can be seen in Table III, is that the micelles of mPEG-Ba7.5 have higher release
efficiency than other studied formulations and mPEG-Sa5 have the lowest release effi-
ciency.
CONCLUSIONS
Amphiphilic block copolymers of mPEG-Ma, mPEG-Sa, mPEG-Ba formed micelles
in aqueous solution. The advantage of these conjugates is that they can be synthesized
in a single-step reaction and the CMC values of the copolymers are low. These low CMC
values indicate their ability to form stable micelles and keep their intact structure upon
dilution with body fluids. Increasing in hydrophobic chain length of fatty acids used in
the formation of micelles caused a decrease of CMC values and greater encapsulation of
etoposide in the hydrophobic core of the micelles, and meanwhile enhanced the drug
solubility. The mPEG-Ma5 copolymer, with the lowest drug to polymer ratio of 1/20,
had higher loading efficiency compared to other ratios. The size of the prepared micelles
was generally between 12 and 150 nm, which can prevent the risk of embolism upon
parenteral administration. The mPEG-Ma copolymer micelles had the smallest particle
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Fig. 4. In vitro etoposide release profiles from different formulations of mPEG-Ma, mPEG-Sa and
mPEG-Ba micelles at pH 7.4. The results are mean ± SD (n = 3).
size due to smaller hydrophobic fatty acid chain compared to other fatty acids. The in vi-
tro release of etoposide from drug-loaded micelles was generally about 80 percent of the
loaded drug within 5 h. This release pattern shows a suitable system for middle-term
drug delivery. The optimum conditions for the production of etoposide micelles were
obtained with 5 % drug in mPEG-Ma. These micelles showed the smallest particle size
and maximum drug loading and drug release efficiency.
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S A @ E T A K
Optimizacija svojstava samoorganiziranja graft kopolimera metoksi poli(etilen
glikola) i masnih kiselina pri pripravi nanonosa~a s uklopljenim etopozidom
JALEH VARSHOSAZ, FARSHID HASANZADEH i MOJTABA ESLAMDOOST
Cilj je rada bio ispitati svojstva samoorganiziranja micela pripravljenih od graft ko-
polimera metoksipolietilenglikola (mPEG) i masnih kiselina razli~ite duljine lanca za
uklapanje etopozida. Sintetizirana su tri amfifilna kopolimera povezivanjem miristin-
ske, stearinske i beheni~ne kiseline esterskom vezom s mPEG. Veli~ina i zeta-potencijal
micela odre|eni su metodom dinami~kog raspr{ivanja svjetlosti. Micele s uklopljenim
etopozidom pripravljene su film-metodom pri razli~itim omjerima lijeka i kopolimera.
Osloba|anje lijeka iz micela ispitano je metodom dijalize. Struktura kopolimera potvr-
|ena je 1H NMR i FTIR spektroskopijom. Odre|ivanjem kriti~nih micelizacijskih kon-
centracija utvr|eno je da se s pove}anjem duljine hidrofobnog lanca na kopolimerima
stvaraju termodinami~ki stabilnije micele. Me|u sintetiziranim kopolimerima, micele
gra|ene od kopolimera mPEG i beheni~ne kiseline imaju najbolji solubilizacijski kapaci-
tet za etopozid. U~inkovitost uklapanja lijeka u micele ovisi o duljini hidrofobnog dijela
u kopolimeru i omjeru lijeka i kopolimera. Najve}a u~inkovitost uklapanja lijeka utvr-
|ena je za micele mPEG i miristinske kiseline pri omjeru lijeka i kopolimera 1:20. Oko
80% uklopljenog lijeka osloba|a se iz micela tijekom 5 sati.
Klju~ne rije~i: metoksi poli(etilen glikol), masne kiseline, micele, etopozid
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